These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32532388)

  • 1. Metformin and Berberine suppress glycogenolysis by inhibiting glycogen phosphorylase and stabilizing the molecular structure of glycogen in db/db mice.
    Liu X; Wang K; Zhou J; Sullivan MA; Liu Y; Gilbert RG; Deng B
    Carbohydr Polym; 2020 Sep; 243():116435. PubMed ID: 32532388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with oleanolic acid and metformin as a synergistic treatment for diabetes.
    Wang X; Chen Y; Abdelkader D; Hassan W; Sun H; Liu J
    J Diabetes Res; 2015; 2015():973287. PubMed ID: 25789330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice.
    Lyu Y; Li D; Yuan X; Li Z; Zhang J; Ming X; Shaw PC; Zhang C; Kong APS; Zuo Z
    Phytomedicine; 2022 Jul; 101():154099. PubMed ID: 35489323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. II. Anti-hyperglycemic effects in diabetic animal models.
    Furukawa S; Murakami K; Nishikawa M; Nakayama O; Hino M
    J Antibiot (Tokyo); 2005 Aug; 58(8):503-6. PubMed ID: 16266121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular structural differences between type-2-diabetic and healthy glycogen.
    Sullivan MA; Li J; Li C; Vilaplana F; Stapleton D; Gray-Weale AA; Bowen S; Zheng L; Gilbert RG
    Biomacromolecules; 2011 Jun; 12(6):1983-6. PubMed ID: 21591708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rate of degradation of liver glycogen phosphorylase is specifically decreased in the C57BL/KsJ-db/db mouse.
    Roesler WJ; Nijjar MS; Khandelwal RL
    Mol Cell Biochem; 1989 Jun; 87(2):147-52. PubMed ID: 2770718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of Liver Glycogen Storage in the db/db Animal Model of Type 2 Diabetes: A Potential Target for Future Therapeutics?
    Sullivan MA; Harcourt BE; Xu P; Forbes JM; Gilbert RG
    Curr Drug Targets; 2015; 16(10):1088-93. PubMed ID: 26212261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fasting on liver glycogen structure in rats with type 2 diabetes.
    Wang L; Liu Q; Wang M; Du Y; Tan X; Xu B; Cheung U; Li E; Gilbert RG; Tang D
    Carbohydr Polym; 2020 Jun; 237():116144. PubMed ID: 32241436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin.
    Heishi M; Ichihara J; Teramoto R; Itakura Y; Hayashi K; Ishikawa H; Gomi H; Sakai J; Kanaoka M; Taiji M; Kimura T
    Diabetologia; 2006 Jul; 49(7):1647-55. PubMed ID: 16752183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic glycogen metabolism in the db/db mouse.
    Roesler WJ; Pugazhenthi S; Khandelwal RL
    Mol Cell Biochem; 1990 Feb; 92(2):99-106. PubMed ID: 2407941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver glycogen fragility in the presence of hydrogen-bond breakers.
    Tan X; Wang Z; Cheung U; Hu Z; Liu Q; Wang L; Sullivan MA; Cozzolino D; Gilbert RG
    Int J Biol Macromol; 2024 May; 268(Pt 1):131741. PubMed ID: 38649083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic properties of glycogen synthase and phosphorylase and structural aspects of glycogen in the db/db mouse liver.
    Roesler WJ; Khandelwal RL
    Diabetes; 1986 Feb; 35(2):210-6. PubMed ID: 3080350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oxytetracycline treatment on enzymes of hepatic glycogen metabolism in genetically diabetic (db/db) mice.
    Benzo CA
    Biochem Med Metab Biol; 1987 Feb; 37(1):42-50. PubMed ID: 3105560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related changes in hepatic glycogen metabolism in the genetically diabetic (db/db) mouse.
    Roesler WJ; Khandelwal RL
    Diabetes; 1985 Apr; 34(4):395-402. PubMed ID: 2982686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal changes of glycogen molecular structure in healthy and diabetic mice.
    Hu Z; Deng B; Tan X; Gan H; Li C; Nada SS; Sullivan MA; Li J; Jiang X; Li E; Gilbert RG
    Carbohydr Polym; 2018 Apr; 185():145-152. PubMed ID: 29421051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine Improves the Protective Effects of Metformin on Diabetic Nephropathy in db/db Mice through Trib1-dependent Inhibiting Inflammation.
    Zhang B; Zhang X; Zhang C; Sun G; Sun X
    Pharm Res; 2021 Nov; 38(11):1807-1820. PubMed ID: 34773184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway.
    Xie X; Li W; Lan T; Liu W; Peng J; Huang K; Huang J; Shen X; Liu P; Huang H
    Endocr J; 2011; 58(9):761-8. PubMed ID: 21705841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendrobium officinale polysaccharide ameliorates diabetic hepatic glucose metabolism via glucagon-mediated signaling pathways and modifying liver-glycogen structure.
    Liu Y; Yang L; Zhang Y; Liu X; Wu Z; Gilbert RG; Deng B; Wang K
    J Ethnopharmacol; 2020 Feb; 248():112308. PubMed ID: 31622745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic metformin treatment of hepatic and muscle glycogen metabolism in KK mice.
    Reddi AS; Jyothirmayi GN
    Biochem Med Metab Biol; 1992 Apr; 47(2):124-32. PubMed ID: 1515171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen structure in type 1 diabetic mice: Towards understanding the origin of diabetic glycogen molecular fragility.
    Hu Z; Li E; Sullivan MA; Tan X; Deng B; Gilbert RG; Li C
    Int J Biol Macromol; 2019 May; 128():665-672. PubMed ID: 30708007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.